Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DNLI - Denali Therapeutics Inc.
17.8 M
LAST VALUE
-4.03%
2 YEAR CAGR
-28.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR